Subscribe to our Email Alerts

Island Pharmaceuticals
  • About Us
    • Island at a glance
    • Board
    • Key Management
    • Scientific Advisory Board
    • Collaborations
  • Science
    • About ISLA-101
    • Scientific Publications
    • Drug repurposing and benefits
    • Disease and drug terms explained
  • Investor Centre
    • Investor Welcome
      • Clinical programme
    • ASX Announcements
    • Presentations
    • Prospectus
    • Financial Reports
    • Share Price Information
    • Shareholder Services
    • Investor Fact Sheet
    • Corporate Governance
    • Corporate Directory
    • International Investors
    • Research Coverage
    • AGM
  • Media
    • News
    • IslandWatch Newsletter
  • Contact
    • Contact Us
    • Subscribe for Email Alerts
Media
Media > News
  • News
  • IslandWatch Newsletter

News

Filter by Year:2025 2024 2023 2022 2021 2020 
22-Dec-2023
Island Pharmaceuticals kicks off dosing for third cohort of ISLA-101 single ascending dose study for dengue treatment
15-Dec-2023
Island Pharmaceuticals secures loan facility with Radium Capital based on forecast R&D tax incentive claim
12-Dec-2023
Island Pharmaceuticals doses second cohort of subjects in ISLA-101 Single Ascending Dose study
5-Dec-2023
Island MD David Foster speaks to Bulls N' Bears about ISLA-101 and more
1-Dec-2023
Island Pharmaceuticals appoints new joint company secretary
24-Nov-2023
Island Pharmaceuticals kicks off "critical" study in Dengue fight
22-Nov-2023
Island Pharma one step closer to ISLA-101 dosing
16-Nov-2023
Island Pharmaceuticals gets ready to tackle mosquito-borne diseases as warmer climate accelerates spread
12-Nov-2023
Island Pharmaceuticals initiates screening for ISLA-101 study to combat mosquito-borne disease
10-Nov-2023
Island Pharmaceuticals nets over $300,000 in R&D tax refund
  • 1
  • 2
  • 3
  •  Next

NOTICE

It has come to the company's attention that unauthorised individuals may be falsely claiming to represent Island Pharmaceuticals Limited in employment offers and recruitment communications. Please be advised that all legitimate employment opportunities are advertised through official company channels, the company's social media channels and via authorised recruitment partners.

Island Pharmaceuticals Limited will never request payment, personal financial information, or conduct interviews via unofficial platforms. If you receive a suspicious message or offer, please report it to us immediately at henry.jordan@sdir.com.au

Your safety and security are important to us.

Kind regards,
Island Pharmaceuticals Limited

Quick Links

Contact Us

Island Pharmaceuticals
Suite 201, 697 Burke Road
Camberwell, Victoria 3124

info@islandpharmaceuticals.com

www.islandpharmaceuticals.com

Email Alerts

Which of the following group do you best fit?

 

Follow Us

Follow Us

Site Map Privacy Search
Copyright © Island Pharmaceuticals
Site Map Privacy Search
Site by